HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 41 - 48)

Why do heroin users refuse to participate in a heroin-assisted treatment trial?

Demaret I., Litran G., Magoga C., Deblire C., Dupont A., De Roubaix J., Lemaître A., and Ansseau M.

Summary: Background: Heroin-assisted treatment (HAT) can improve the condition of heroin addicts resistant to other treatments. However, in a new HAT trial in Belgium fewer subjects than expected were included. Aim: Our research team explored the reasons given by heroin users explaining why they did not want to participate. Materials and methods: In 2011, during the trial recruitment, we interviewed heroin users (n=52) who were never met by the research team during the recruitment process of the trial. Results: Of those 52 heroin users, 25 were afraid of the limited length of the HAT and 11 feared becoming more dependent with HAT. Conclusion: A trial for a limited length of time can demotivate heroin users who could otherwise have benefited from this new program.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page